Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Abstract

The risk of short-term mortality, heart failure and stent thrombosis is highest for STEMI patients after PCI. Therapies to reduce stent thrombosis and heart failure appear to be most important in decreasing mortality in patients with STEMI or NSTEMI undergoing PCI.

Are BVS suitable for ACS patients? Support from a large single center real live registry

“…Rate of mortality in ACS patients is worse compared with patients who present with stable CAD [42][43][44][45]. In our patient cohort, mortality was 0% in the ACS population probably reflecting our exclusion criteria for the STEMI population (exclusion of patients presenting with cardiogenic shock).…”

6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation

“…A Swedish registry analysis indicated the evolution of percutaneous coronary intervention; implanted total stent length per patient has increased over the past 20 years in daily clinical practice (17). Long stent implantation for diffuse long lesions has a high risk for stent thrombosis, myocardial infarction, and target lesion failure, even with the use of newgeneration DES (18)(19)(20)(21).…”

Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease

“…Coronary artery bypass graft (CABG) surgery has been recommended as the standard treatment for patients with ULMD (2). However, with advances in interventional cardiology, percutaneous coronary intervention (PCI) has been increasingly used for ULMD, and outcomes of ULMD PCI have significantly improved over time (3)(4)(5)(6).…”